Nuveen Asset Management’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $275K | Buy |
164,790
+58,896
| +56% | +$98.4K | ﹤0.01% | 3144 |
|
|
2024
Q3 | $193K | Hold |
105,894
| – | – | ﹤0.01% | 3230 |
|
|
2024
Q2 | $639K | Hold |
105,894
| – | – | ﹤0.01% | 2911 |
|
|
2024
Q1 | $1.18M | Hold |
105,894
| – | – | ﹤0.01% | 2631 |
|
|
2023
Q4 | $1.58M | Buy |
105,894
+18,241
| +21% | +$272K | ﹤0.01% | 2516 |
|
|
2023
Q3 | $421K | Sell |
87,653
-10,411
| -11% | -$50K | ﹤0.01% | 2899 |
|
|
2023
Q2 | $736K | Hold |
98,064
| – | – | ﹤0.01% | 2783 |
|
|
2023
Q1 | $443K | Sell |
98,064
-7,001
| -7% | -$31.6K | ﹤0.01% | 2834 |
|
|
2022
Q4 | $1.18M | Sell |
105,065
-10,556
| -9% | -$119K | ﹤0.01% | 2622 |
|
|
2022
Q3 | $1.11M | Sell |
115,621
-1,198
| -1% | -$11.5K | ﹤0.01% | 2707 |
|
|
2022
Q2 | $945K | Buy |
116,819
+68,193
| +140% | +$552K | ﹤0.01% | 2806 |
|
|
2022
Q1 | $872K | Sell |
48,626
-15,230
| -24% | -$273K | ﹤0.01% | 2859 |
|
|
2021
Q4 | $1.37M | Sell |
63,856
-1,329
| -2% | -$28.6K | ﹤0.01% | 2736 |
|
|
2021
Q3 | $4.81M | Sell |
65,185
-29,752
| -31% | -$2.2M | ﹤0.01% | 2234 |
|
|
2021
Q2 | $5.19M | Buy |
94,937
+8,359
| +10% | +$457K | ﹤0.01% | 2226 |
|
|
2021
Q1 | $6.39M | Buy |
86,578
+39,673
| +85% | +$2.93M | ﹤0.01% | 2048 |
|
|
2020
Q4 | $4.04M | Buy |
46,905
+10,997
| +31% | +$948K | ﹤0.01% | 2178 |
|
|
2020
Q3 | $1.36M | Buy |
+35,908
| New | +$1.36M | ﹤0.01% | 2551 |
|